Advanced in Embryonal Tumor with Multilayered Rosettes

Dr. Arul Mahadevan

Radiation Oncology
Radiation Oncology Associates, PA
1 Elliot Way, Department Of Radiation Oncology, 
Manchester, NH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Embryonal Tumor with Multilayered Rosettes
Radiation Oncology Associates, PA
1 Elliot Way, Department Of Radiation Oncology, 
Manchester, NH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Arul Mahadevan is a Radiation Oncologist in Manchester, New Hampshire. Dr. Mahadevan is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Mahadevan is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in OH
Hospital Affiliations
York Hospital
Wentworth-Douglass Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

RADIATION ONCOLOGY ASSOCIATES, PA
1 Elliot Way, Department Of Radiation Oncology, Manchester, NH 03103
Other Locations
RADIATION ONCOLOGY ASSOCIATES, PA
789 Central Ave, Dover, NH 03820
RADIATION ONCOLOGY ASSOCIATES, PA
1 Hospital Dr, Lowell, MA 01852

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

6 Total Publications

Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.
Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.
Journal: Practical radiation oncology
Published: November 10, 2019
Similar Doctors
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Helen A. Shih
Radiation Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Helen A. Shih
Radiation Oncology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (46.9 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Helen Shih is a Radiation Oncologist in Boston, Massachusetts. Dr. Shih is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Meningioma, Brain Tumor, Astrocytoma, Acoustic Neuroma, and Tissue Biopsy. Dr. Shih is currently accepting new patients.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Daphne A. Haas-Kogan
Radiation Oncology | Anesthesiology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Daphne A. Haas-Kogan
Radiation Oncology | Anesthesiology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (47.8 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daphne Haas-Kogan is a Radiation Oncologist and an Anesthesiologist in Boston, Massachusetts. Dr. Haas-Kogan is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Gliomatosis Cerebri, Posterior Fossa Tumor, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Haas-Kogan is currently accepting new patients.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Kevin S. Oh
Radiation Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Kevin S. Oh
Radiation Oncology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (46.9 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kevin Oh is a Radiation Oncologist in Boston, Massachusetts. Dr. Oh is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Meningioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Brain Tumor. Dr. Oh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mahadevan's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile